Hot Marijuana IPOs: What’s Next for This Flourishing Industry

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is poised to soar as technology gains greater traction in the emerging legal marijuana industry.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Provider of technology infrastructure for the marijuana industry Akerna (NASDAQ:KERN) has been one of the hottest IPOs of the cannabis industry in recent months. Since listing via a merger of special purpose acquisition company, MTech Acquisition Corp. and marijuana regulatory compliance technology provider MJ Freeway LLC, the company saw its price more than triple in two days to US$65 a share, then pull back sharply to close US$21.60 per share at the end of June 2019.

Clearly, there is plenty of hype still surrounding the legal cannabis industry, providing investors with speculative opportunities to generate significant returns. Akerna provides marijuana cultivators, sellers and governments with technology platforms that allow them to track cannabis across all segments of the supply chain, from seeds to final products distributed to retail consumers.

Since its inception in 2010, it has made US$10 billion in sales and plans to scale its products to meet demand from the growing legal marijuana market.

Akerna’s software includes inventory control and growth management applications for cultivators, which allow them to boost efficiency. It also offers data solution applications that allow governments to track cannabis plants from seed to sale. This permits more effective monitoring of the burgeoning legal marijuana industry and its regulatory compliance while enhancing consumer safety.

Is this the next hot marijuana IPO?

An impending IPO is vaporizer manufacturer Pax Labs founded in 2007, which is focused on the design and development of vaporizers and other delivery systems for cannabis flower and oil. The consumption of marijuana through vaporizers and similar devices is expected to become one of the most widely accepted methods for consuming the psychoactive substance.

Pax’ devices have become highly popular, and their rapidly growing acceptance, along with rising demand saw the company ink deals with Aphria and Aurora Cannabis (TSX:ACB)(NYSE:ACB) to obtain supplies of cannabis extracts for its Pax Era pen-and-pod vape devices.

Aurora is among my top picks in the industry because of its focus on bulking up its production and processing capacity as well as its reported low production cost of $1.42 per gram of dried cannabis sold. This, along with its ever-expanding distribution network makes it one of the best positioned large-scale cannabis cultivators to take advantage of the anticipated surge in demand for marijuana once edibles, extracts and topicals are legalized.

Aurora’s appeal as an investment is enhanced by its leading position in Latin America. It has established operations in Colombia and Uruguay, the latter of which was the first country to legalize the adult recreational consumption of marijuana. Colombia, because of its unique characteristics, including temperate equatorial climate zones and unique globally recognized cannabis strains, is set to become a leading marijuana cultivating jurisdiction.

Aurora is developing 124,000 square feet of greenhouse space in Colombia and a further one million square feet in Uruguay. It also has the only GMP-compliant cannabis science laboratory in South America, which is in the process of being developed to provide 150,000 kilograms of extraction capacity annually.

While these characteristics make Aurora a compelling proposition for investors seeking exposure to cannabis, there is a major shake-up looming for cultivators because there are very few barriers to entry. As growers focus on cutting costs and building capacity, it will create a “race to the bottom,” where margins will become so thin that many cultivators will no longer be able to compete forcing them to shutter operations.

Technology applications are where the real intellectual capital, competitive advantage and the potential to build a wide economic moat exists.

What does it all mean?

Investors should to watch the cannabis IPO space closely, as companies offering marijuana delivery systems, biotechnology solutions and technology platforms to manage what will be ever-steeper regulatory requirements will eventually possess the widest moats. It is here that the real profits can be made, particularly as cannabis consumption becomes more mainstream and the market expands globally to be worth around US$66 billion in the next five years.

This will trigger a scramble among the major cultivators like Aurora as they transition from energy intensive indoor cultivation to open-air greenhouses in jurisdictions with favourable climates such as Colombia and bolster efficiency by adding technology platforms to their operations.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Matt Smith has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »